Hypersensitivity Reactions: Types and Mechanisms

Lecture Overview

  • Focus on hypersensitivity reactions, particularly types two, three, and four.

Type One Hypersensitivity Recap

  • Previously discussed type one hypersensitivity, which is immediate and mediated by IgE antibodies.

  • Key symptom of anaphylaxis: vascular permeability.

    • This symptom leads to a drop in blood pressure and inadequate oxygen supply to organs, making it the most life-threatening aspect of anaphylaxis.

Hygiene Hypothesis

  • Discusses the increasing prevalence of hypersensitivity in Western nations.

  • Central Idea: Overcleanliness reduces childhood exposure to pathogens, commensals, and animals.

    • Urban lifestyles limit interactions with farm animals, which contributed to immune development in earlier times.

  • Vaccination may inhibit the developing immune system's ability to face natural infections due to the following reasons:

    • Immune systems that do not encounter infections may not fully develop effective responses.

    • Early exposure to specific infections can strengthen immunity.

  • Excessive use of antibiotics contributes to premature termination of infections, resulting in less immune system training.

  • Consequences include a poorly educated immune system that targets harmless substances, leading to allergies.

  • Research indicates that early exposure to food allergens can decrease allergy development (example: peanuts).

Basophils

  • Basophils are crucial in initiating T helper 2 (Th2) responses.

    • Produce interleukin 4 (IL-4) and interleukin 13 (IL-13).

    • Can drive class switching of antibodies to IgE and IgG4 by interacting with B cells through CD40 ligand.

Lipid Mediators in Inflammation

  • Discusses the role of prostaglandins and leukotrienes.

    • Produced from arachidonic acid via COX and 5-lipoxygenase pathways during inflammatory responses.

    • These mediators are targeted by NSAIDs, which include medicinal properties for treating allergies and inflammation.

    • Aspirin acts by inhibiting prostaglandin synthase, blocking production of prostaglandins.

Introduction to Types Two, Three, and Four Hypersensitivity

  • Focus will shift beyond type one hypersensitivity to type two, three (both involving antibodies), and type four (T cell-mediated).

Type Two Hypersensitivity

  • Caused by IgG antibodies targeting altered cellular structures.

    • Commonly involves reactions induced by drugs, notably penicillin.

  • Mechanism:

    • Altered structures on host cells lead to recognition as foreign by the immune system, promoting an antibody response.

    • Antigen-bound antibodies activate the classical complement pathway and induce phagocytosis.

  • Penicillin example:

    • Can modify the surface of erythrocytes, resulting in immune recognition and antibody production against penicillin-modified blood cells.

  • Blood transfusion implications:

    • Transfusion reactions can be life-threatening if the antibody against donor blood type antigens is present (e.g., ABO system).

    • Universal donor: Type O blood does not have A or B antigens that would be recognized as foreign by other blood types.

ABO System of Blood Group Antigens
  • Blood groups determined by carbohydrate antigens on erythrocyte surface:

    • Type A: terminal residue galNAC (N-acetylgalactosamine).

    • Type B: terminal residue galactose.

    • Type O: absence of these terminal residues.

  • Antibodies develop against unlike blood group antigens due to similarities with bacterial antigens.

Type Three Hypersensitivity

  • Mediated by immune complexes formed from antigen-antibody interactions.

  • Mechanism:

    • Immune complexes can deposit in tissues, activating complementary processes.

    • Lead to inflammation and variety of diseases (e.g., serum sickness, Arthus reaction).

  • Examples resulting from exposure to nonhuman proteins:

    • Antivenoms derived from horse serum.

    • Therapies using monoclonal antibodies from other animals (e.g., mice).

Clinical Manifestations
  • Vasculitis: Inflammation of blood vessels due to immune complex deposition.

  • Nephritis: Immune complex deposition in renal glomeruli.

  • Arthritis: Immune complex deposition in joints.

  • Arthus Reaction: Localized immune complexes causing local reactions (e.g., farmer's lung due to inhaled antigens).

Immune Complex Size Dynamics
  • Small immune complexes are formed during a stage of high antigen concentration relative to antibodies.

  • Large immune complexes arise when antigens and antibodies are in similar concentrations, leading to increased tissue damage due to deposition.

Type Four Hypersensitivity (DTH)

  • Mediated by antigen-specific T cells (specifically CD4+ Th1 cells).

  • Mechanism:

    • Takes days to develop, with symptoms appearing 24-72 hours after re-exposure to the antigen.

  • Examples:

    • Insect bites.

    • Tuberculin skin tests (reactive to Mycobacterium materials).

    • Contact dermatitis due to substances like poison ivy (pentadecatechol).

    • Celiac disease, where T cell-mediated damage leads to atrophy of the intestinal villi through gliadin (gluten protein).

Delayed Type Hypersensitivity Response
  • Characterized by localized skin swelling, redness, and itchiness due to T cell and macrophage activity at the challenge site.

  • Involves cytokine-driven processes enhancing macrophage recruitment and edema formation.

Granuloma Formation
  • Granulomas formed in response to bacterial pathogens like Mycobacterium tuberculosis contain infection within a walled-off structure consisting of macrophages and lymphocytes, potentially leading to necrotic tissue in the center (caseous necrosis).

Conclusions

  • Summary of hypersensitivity types:

    • Type Two: antibody responses against altered host molecules.

    • Type Three: immune complexes leading to inflammation and tissue damage.

    • Type Four: T cell-mediated reactions causing delayed local response compared to immediate hypersensitivity reactions.